Adverum Biotechnologies, Inc. (ADVM)
NASDAQ: ADVM · Real-Time Price · USD
2.340
-0.050 (-2.09%)
At close: Aug 1, 2025, 4:00 PM
2.320
-0.020 (-0.85%)
After-hours: Aug 1, 2025, 6:51 PM EDT

Adverum Biotechnologies Stock Forecast

ADVM's stock price has decreased by -68.46% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

The 5 analysts that cover Adverum Biotechnologies stock have a consensus rating of "Strong Buy" and an average price target of $23.8, which forecasts a 917.09% increase in the stock price over the next year. The lowest target is $4.00 and the highest is $40.

Price Target: $23.80 (+917.09%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$4.00$23.8$30$40
Change+70.94%+917.09%+1182.1%+1609.4%
* Price targets were last updated on Jun 26, 2025.

Analyst Ratings

The average analyst rating for Adverum Biotechnologies stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingFeb '25Mar '25Apr '25May '25Jun '25Jul '25
Strong Buy444333
Buy111111
Hold111111
Sell000000
Strong Sell000000
Total666555

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Mizuho
Mizuho
Buy
Maintains
$16$12
BuyMaintains$16$12+412.82%Jun 26, 2025
RBC Capital
RBC Capital
Hold
Maintains
$5$4
HoldMaintains$5$4+70.94%May 15, 2025
Chardan Capital
Chardan Capital
Strong Buy
Maintains
$33
Strong BuyMaintains$33+1,310.26%May 15, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$30
Strong BuyReiterates$30+1,182.05%May 15, 2025
Chardan Capital
Chardan Capital
Strong Buy
Maintains
$40$33
Strong BuyMaintains$40$33+1,310.26%Apr 17, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
193.80K
from 1.00M
Decreased by -80.62%
Revenue Next Year
230.27K
from 193.80K
Increased by 18.82%
EPS This Year
-6.26
from -6.62
EPS Next Year
-3.76
from -6.26
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026FY 2027
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026Dec 31, 2027
Revenue
-7.50M-3.60M1.00M193.80K230.27K291.38K
Revenue Growth
-----72.22%-80.62%18.82%26.54%
EPS
-13.80-14.85-15.57-12.11-6.62-6.26-3.76-4.58
EPS Growth
--------
Forward PE
--------
No. Analysts
-----775
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20252026202720282029
High997,500948,150899,850
Avg193,800230,265291,383
Lown/an/an/a

Revenue Growth

Revenue Growth20252026202720282029
High
-0.3%
389.2%
290.8%
Avg
-80.6%
18.8%
26.5%
Low---

EPS Forecast

EPS20252026202720282029
High-3.72-2.15-2.91
Avg-6.26-3.76-4.58
Low-8.04-6.91-6.37

EPS Growth

EPS Growth20252026202720282029
High---
Avg---
Low---
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.